Sandoz, a division of Novartis, has halted the worldwide distribution of its generic version of Zantac, a popular heartburn medication. In a statement to Fox 11, Dana Kahn Cooper, a spokesperson for ...
Shares of drugmakers Sanofi, GlaxoSmithKline (GSK), Haleon and Pfizer have taken a hit this week in response to investors' growing fears about litigation related to the recalled heartburn drug Zantac.
Even though drugs have different effects on different individuals, research reveals that Zantac can be extremely harmful to the liver for a majority of individuals. It can lead to acute liver damage, ...
Not a single jury in eight trials has sided with plaintiffs suing over Zantac, although three of them ended in mistrials. Boehringer Ingelheim called the Delaware Supreme Court’s ruling, which applied ...
(Bloomberg) -- A Delaware judge threw out lawsuits seeking to link the heartburn drug Zantac to cancer, freeing makers of the product from facing trials in the state over the cases. Superior Court ...
Facing tens of thousands of lawsuits over cancer risks on the popular heartburn drug Zantac, GSK has argued there's "no consistent or reliable evidence" that the medicine causes cancer. But a new ...
Even as GSK defends itself against thousands of personal injury lawsuits relating to its sale of heartburn pill Zantac, a whistleblower lawsuit from the laboratory that first raised alarm bells about ...
The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above information ...
Did you know that Zantac can have some pretty nasty side effects? Many people don't, and it's okay if you are one of them. Turns out, there are quite a few things that can go wrong if you're taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results